Table 4.
Stability estimates for CPM within and between sessions stratified by sex for clinical and healthy cohorts
| |
|
Females |
Males |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Clinical cohort | ICC’s for the absolute difference (95% CI) | ICC’s for the percent change (95% CI) | SEM* | MDC* | ICC’s for the absolute difference (95% CI) | ICC’s for the percent change (95% CI) | SEM* | MDC* | |
| Within session |
CPM trial 1-CPM trial 2 (baseline) |
0.63 (0.33-0.80) |
0.57 (0.19-0.78) |
5.83 |
16.16 |
0.49 (0.21-0.67) |
0.39 (0.05-0.61) |
7.33 |
20.32 |
| CPM trial 1-CPM trial 2 (3 months) |
0.75 (0.43-0.89) |
0.73 (0.36-0.89) |
4.25 |
11.78 |
0.58 (0.32-0.73) |
0.41 (-0.03-0.66) |
6.50 |
18.02 |
|
| |
Healthy cohort |
||||||||
| Within session |
CPM trial 1-CPM trial 2 (day 1) |
0.60 (0.42-0.72) |
0.55 (0.34-0.69) |
7.45 |
20.65 |
0.79 (0.67-0.87) |
0.66 (0.45-0.79) |
4.26 |
11.81 |
| CPM trial 1-CPM trial 2 (day 3) |
0.71 (0.57-0.80) |
0.61 (0.42-0.74) |
7.28 |
20.18 |
0.74 (0.58-0.84) |
0.52 (0.22-0.71) |
4.40 |
12.20 |
|
| CPM trial 1-CPM trial 2 (day 5) |
0.64 (0.47-0.75) |
0.74 (0.61-0.82) |
7.49 |
20.76 |
0.83 (0.73-0.89) |
0.48 (0.13-0.68) |
4.21 |
11.66 |
|
| Between session |
CPM trial 1 (day1)-CPM trial 1 (day3)-CPM trial 1 (day5) |
0.65 (0.51-0.75) |
0.62 (0.47-0.73) |
7.93 |
21.98 |
0.82 (0.73-0.88) |
0.60 (0.40-0.75) |
4.64 |
12.86 |
| CPM trial 2 (day1)-CPM trial 2 (day3)-CPM trial 2 (day5) | 0.63 (0.49-0.74) | 0.61 (0.46-0.73) | 7.15 | 19.82 | 0.82 (0.74-0.88) | 0.58 (0.35-0.74) | 3.32 | 9.20 | |
*SEM and MDC were calculated using ICC’s for the absolute difference of CPM.